152 related articles for article (PubMed ID: 11016885)
1. Proteasome inhibitors: from in vitro uses to clinical trials.
Rivett AJ; Gardner RC
J Pept Sci; 2000 Sep; 6(9):478-88. PubMed ID: 11016885
[TBL] [Abstract][Full Text] [Related]
2. Not just research tools--proteasome inhibitors offer therapeutic promise.
Goldberg AL; Rock K
Nat Med; 2002 Apr; 8(4):338-40. PubMed ID: 11927937
[No Abstract] [Full Text] [Related]
3. The proteasome: a new target for novel drug therapies.
Elliott PJ; Ross JS
Am J Clin Pathol; 2001 Nov; 116(5):637-46. PubMed ID: 11710679
[TBL] [Abstract][Full Text] [Related]
4. The multicatalytic proteinase complex.
Rivett AJ
Revis Biol Celular; 1989; 20():113-23. PubMed ID: 2700095
[TBL] [Abstract][Full Text] [Related]
5. Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy.
Dou QP; Smith DM; Daniel KG; Kazi A
Prog Cell Cycle Res; 2003; 5():441-6. PubMed ID: 14593738
[TBL] [Abstract][Full Text] [Related]
6. The proteasome system and proteasome inhibitors in stroke: controlling the inflammatory response.
Di Napoli M; Papa F
Curr Opin Investig Drugs; 2003 Nov; 4(11):1333-42. PubMed ID: 14758773
[TBL] [Abstract][Full Text] [Related]
7. [Proteasome inhibitors: induction of apoptosis as new therapeutic option in prostate cancer].
Tahmatzopoulos A; Gudegast C; Stöckle M; Wullich B; Unteregger G; Zwergel U; Zwergel T
Aktuelle Urol; 2004 Nov; 35(6):491-6. PubMed ID: 15526229
[TBL] [Abstract][Full Text] [Related]
8. [Proteasome inhibitors].
Hatake K; Mishima Y; Terui Y
Gan To Kagaku Ryoho; 2004 Jul; 31(7):999-1002. PubMed ID: 15272575
[TBL] [Abstract][Full Text] [Related]
9. Development of proteasome inhibitors in oncology and autoimmune diseases.
Bennett MK; Kirk CJ
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):616-25. PubMed ID: 18729013
[TBL] [Abstract][Full Text] [Related]
10. Cancer research. Taking garbage in, tossing cancer out?
Garber K
Science; 2002 Jan; 295(5555):612-3. PubMed ID: 11809952
[No Abstract] [Full Text] [Related]
11. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.
Gaedicke S; Firat-Geier E; Constantiniu O; Lucchiari-Hartz M; Freudenberg M; Galanos C; Niedermann G
Cancer Res; 2002 Dec; 62(23):6901-8. PubMed ID: 12460905
[TBL] [Abstract][Full Text] [Related]
12. Assays for proteasome inhibition.
Elliott PJ; Soucy TA; Pien CS; Adams J; Lightcap ES
Methods Mol Med; 2003; 85():163-72. PubMed ID: 12710207
[No Abstract] [Full Text] [Related]
13. Effects of protease inhibitors on binding of sperm to the vitelline coat of ascidian eggs: implications for participation of a proteasome (multicatalytic proteinase complex).
Takizawa S; Sawada H; Someno T; Saitoh Y; Yokosawa H; Hoshi M
J Exp Zool; 1993 Sep; 267(1):86-91. PubMed ID: 8376953
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib as a potential treatment for prostate cancer.
Papandreou CN; Logothetis CJ
Cancer Res; 2004 Aug; 64(15):5036-43. PubMed ID: 15289299
[TBL] [Abstract][Full Text] [Related]
15. Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myeloma.
Oyajobi BO; Mundy GR
Cancer; 2003 Feb; 97(3 Suppl):813-7. PubMed ID: 12548580
[TBL] [Abstract][Full Text] [Related]
16. Treatment of COS-7 cells with proteasome inhibitors or gamma-interferon reduces the increase in caspase 3 activity associated with staurosporine-induced apoptosis.
Brophy VA; Tavaré JM; Rivett AJ
Arch Biochem Biophys; 2002 Jan; 397(2):199-205. PubMed ID: 11795872
[TBL] [Abstract][Full Text] [Related]
17. Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex.
Orlowski M; Wilk S
Arch Biochem Biophys; 2000 Nov; 383(1):1-16. PubMed ID: 11097171
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon.
Bose S; Stratford FL; Broadfoot KI; Mason GG; Rivett AJ
Biochem J; 2004 Feb; 378(Pt 1):177-84. PubMed ID: 14583091
[TBL] [Abstract][Full Text] [Related]
19. The proteasome: a novel therapeutic target in haematopoietic malignancy.
Magill L; Walker B; Irvine AE
Hematology; 2003 Oct; 8(5):275-83. PubMed ID: 14530169
[TBL] [Abstract][Full Text] [Related]
20. MLN-519. Millennium/PAION.
Di Napoli M; Papa F
Curr Opin Investig Drugs; 2003 Mar; 4(3):333-41. PubMed ID: 12735235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
